ICMR

India's COVID-19 Vaccine COVAXIN's Final Trials Could End In 2 Months: Harsh Vardhan
The health minister reiterated the governments plan was to immunise 200 million to 250 millionIndians by July.
By Krishna N Das and Neha Arora, Reuters

To Use Or Not To? Indian Doctors Confusion Over Plasma Therapy Worsens After ICMRs Doubts
While some doctors say they have not seen any benefits from the therapy, others think that shutting off the limited options available to them is counter-productive.
By

Govt Is Underestimating Coronavirus Spread In India, Says Expert
T. Jacob John, formerly with CMC, Vellore, says the government is placing too much faith in laboratories and PCR tests.
By

At 24,850 Cases And 613 Deaths, India Records Highest Single Day COVID Spike So Far
The coronavirus cases in India continue to escalate.
By Press Trust of India

Following Globally Accepted Norms To Fast Track Vaccine; Want To Cut Red Tape, Says ICMR
The body had come under criticism for rushing the process of developing a COVID-19 vaccine.
By Press Trust of India

Punjab Shows How Easily COVID-19 Test Reports Can be Forged In India
A police investigation into an alleged conspiracy in which a privately-owned diagnostic lab and a COVID-19 hospital in Amritsar stand accused of colluding to declare healthy people coronavirus-positive has cast an uncomfortable light on the vagaries of Indias testing infrastructure for the novel coronavirus.
By

India's Use Of HCQ Against Covid-19 May Be Unscientific, Misguided, Says Doctor Who Studied Drug Effect
A study spanning six continents, led by Dr. Mandeep Mehra, looked into the safety and benefit of using Hydroxychloroquine for COVID-19 patients
By

ICMR's Head Of Plasma Therapy Research Answers Questions On COVID
While the Delhi government touted the success of plasma therapy, the Centre was for exercising caution.
By

Test Kit Shortage: ICMR's Crucial Mistakes Wasted India's Lockdown
ICMR was put in charge of COVID-19 testing on February 3 2020. Two months later, the agency is still struggling to source enough tests, compromising India's fight against the novel coronavirus.
By
and